NAMI
TWST icon

Nomura Asset Management International’s Twist Bioscience TWST Stock Holding History

Nomura Asset Management International’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.18M Sell
89,273
-63,414
-42% -$4.13M 0.01% 770
2026
Q1 		$7.26M Buy
152,687
+72,135
+90% +$3.23M 0.01% 735
2025
Q4 		$2.56M Buy
+80,552
New +$2.51M ﹤0.01% 949

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Nomura Asset Management International's TWST Position: Q2 2026 in Review

Nomura Asset Management International reduced its Twist Bioscience (TWST) stake by 42% in Q2 2026, selling an estimated $4.13M and leaving 89,273 shares worth $9.18M. The position accounts for 0.01% of the portfolio, ranked #770.

Nomura Asset Management International first reported a position in TWST in Q4 2025 and has held it in 3 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Nomura Asset Management International held 89,273 shares of Twist Bioscience worth $9.18M as of Q2 2026.
  • Nomura Asset Management International sold 63,414 Twist Bioscience shares in Q2 2026, an estimated $4.13M.
  • Twist Bioscience made up 0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #770 holding.
  • Nomura Asset Management International first reported a position in Twist Bioscience in Q4 2025 and has held it in 3 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.